Baseline features and reasons for nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) study, a colorectal cancer screening trial

Authors

Douglas J Robertson, Geisel School of Medicine at Dartmouth
Jill Elwing, Washington University School of Medicine in St. Louis
et al.

Journal

JAMA Network Open

Publication Date

7-3-2023

Volume

6

Issue

7

First Page

e2321730

Document Type

Open Access Publication

DOI

10.1001/jamanetworkopen.2023.21730

Rights and Permissions

Robertson DJ, Dominitz JA, Beed A, et al. Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial. JAMA Netw Open. 2023;6(7):e2321730. doi:10.1001/jamanetworkopen.2023.21730. This is an open access article distributed under the terms of the CC-BY License. © 2023 Robertson DJ et al. JAMA Network Open.

Recommended Citation

Robertson, Douglas J; Elwing, Jill; and et al., "Baseline features and reasons for nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) study, a colorectal cancer screening trial." JAMA Network Open. 6, 7. e2321730 (2023).
https://digitalcommons.wustl.edu/oa_4/2093

Additional Links

Supplemental material is available for this article at publisher site.